Gerc Vjekoslav, Buksa Marko
Klinika Za Bolesti Srca I Reumatizam, KCU Sarajevo.
Med Arh. 2005;59(6):396-9.
The American guidelines for management of hypertension (JNC 7) and the European guidelines (2003 ESH/ESC) communicate some new moments and attitudes in the treatment of the condition. According to JNC 7, in patients belonging to the prehypertension category (systolic bp 120-139, diastolic bp 80-89), life style modifications are prescribed. The second and third degrees of hypertension have been merged (degree 2). The drugs of choice for majority of the patients, according to INC 7, are thiazide diuretics, alone or in combination with other drugs. The European guidelines have, more or less, preserved the old classification of hypertension. According to the European guidelines, the assessment of global cardiovascular risk is one of the more important factors in making the decision when to begin the therapy of hypertension. In line with the European guidelines, it is not so important which drug will be applied at the beginning of therapy because, in time, most of the patients will be receiving two or three drugs.
美国高血压管理指南(JNC 7)和欧洲指南(2003年ESH/ESC)在该病症的治疗方面传达了一些新观点和态度。根据JNC 7,对于处于高血压前期类别(收缩压120 - 139,舒张压80 - 89)的患者,建议进行生活方式调整。高血压的二级和三级已合并(二级)。根据JNC 7,大多数患者的首选药物是噻嗪类利尿剂,可单独使用或与其他药物联合使用。欧洲指南或多或少保留了高血压的旧分类。根据欧洲指南,评估整体心血管风险是决定何时开始高血压治疗时更为重要的因素之一。按照欧洲指南,治疗开始时使用哪种药物并非那么重要,因为随着时间推移,大多数患者将接受两种或三种药物治疗。